Company
Quantum-Si, Inc.
Headquarters: Guilford, CT, United States
Employees: 153
CEO: Dr. Jonathan M. Rothberg Ph.D.
Quantum-Si, Inc. Categories
United States Healthcare BiotechnologyUnited States Healthcare United States Biotechnology
Top Competitors by Market Capitalization
Industry: Biotechnology
| Company | Market Cap (USD) |
|---|---|
| Novo Nordisk | $309.91 B |
| Vertex Pharmaceuticals Incorporated | $117.36 B |
| CSL Limited | $95.75 B |
| Regeneron Pharmaceuticals, Inc. | $59.14 B |
| Marinomed Biotech AG | $58.56 B |
Sector:
| Company | Market Cap (USD) |
|---|---|
| Lilly | $699.59 B |
| Johnson & Johnson | $374.29 B |
| AbbVie | $336.94 B |
| Novo Nordisk | $309.91 B |
| UnitedHealth Group | $279.90 B |
Detailed Description
Quantum-Si incorporated, a life sciences company, operates single molecule detection platform for sample preparation and sequencing. It offers a proprietary single molecule detection platform for semiconductor industry to field proteomics to enable next generation protein sequencing. The company is based in Guilford, Connecticut. Quantum-Si incorporated is a subsidiary of 4C Holdings I, LLC.
Financials
| Last Financial Reports Date | Dec. 31, 2023 |
| Revenue TTM | $1.1 M |
| EBITDA | $-102,511,000 |
| Gross Profit TTM | $488,000 |
| Profit Margin | 45.10% |
| Operating Margin | -6877.50% |
| Quarterly Revenue Growth | 79.37% |
Stocks & Indices
Quantum-Si, Inc. has the following listings and related stock indices.
Stock: NASDAQ: QSI wb_incandescent